Bharat Parenterals Limited

BSE: BPLPHARMA541096ISIN INE365Y01019

Healthcare
Pharmaceuticals

Share price

₹1,801.35-109.75 (-5.74%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹2,292.15
52W low: ₹880.25
Off 52W high: -21.41%
1M return: +4.29%
3M return: +23.31%
6M return: +40.18%
1Y return: +47.36%
20D avg volume: 1,488
50 DMA: ₹1,706.94
200 DMA: ₹1,348.93

Key ratios Consolidated

Market cap: ₹1,241 Cr
Current price: ₹1,801.35
52W high / low: ₹2,292.15 / ₹880.25
Face value: ₹10.00
P/E: -38.20
P/B: 3.74
EPS (TTM): ₹-43.53
Book value / share: ₹481.93
ROE: —
ROCE: -1.90%
Operating margin: —
Net margin: —
Debt / equity: 0.47
Net debt: ₹144.63 Cr
Interest cover: -0.71
Dividend yield: 0.06%
Dividend / share (TTM): ₹1.00
Payout: —
Cash conversion cycle: 181.1 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	136.28	93.74	99.62	65.19	64.62	116.00	103.98	72.26	71.63	92.51	67.82	59.82
	2.54	1.11	3.63	1.33	3.53	1.06	2.20	2.95	4.21	2.54	2.64	1.26
	138.82	94.85	103.25	66.52	68.15	117.06	106.18	75.21	75.84	95.05	70.46	61.08
	124.83	96.34	111.62	74.80	75.47	114.52	114.48	80.71	91.22	99.82	71.82	55.61
	60.27	40.50	51.35	26.11	31.41	54.83	51.18	45.25	26.94	54.80	47.75	49.67
	8.59	5.12	5.80	3.66	4.73	3.21	6.64	0.48	—	0.64	0.10	—
	21.43	18.84	18.46	17.03	16.49	15.30	18.14	10.98	10.62	9.92	6.64	5.31
	3.12	2.45	2.85	2.90	3.11	3.69	4.22	3.33	2.91	2.77	1.13	0.58
	9.01	8.69	8.63	8.46	8.56	8.60	8.52	8.76	9.01	9.03	3.86	1.83
	22.58	20.05	23.94	14.11	20.39	18.08	30.06	21.97	26.98	23.53	16.14	11.27
	14.00	-1.49	-8.37	-8.28	-7.32	2.54	-8.30	-5.50	-15.38	-4.77	-1.36	5.47
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	14.00	-1.49	-8.37	-8.28	-7.32	2.54	-8.30	-5.50	-15.38	-4.77	-1.36	5.47
	2.18	2.07	-0.21	1.39	1.29	3.41	0.96	2.37	2.14	4.08	1.33	1.83
	11.82	-3.56	-8.16	-9.67	-8.61	-0.87	-9.44	-7.87	-17.52	-8.85	-2.56	3.64
	17.15	-5.17	-11.84	-14.03	-14.00	-1.27	-14.40	-10.00	-27.00	-14.71	-0.62	6.45
Key metrics
	26.13	9.65	3.11	3.08	4.35	14.83	4.44	6.59	-3.46	7.03	3.63	7.88
	19.20%	10.30%	3.10%	4.70%	6.70%	12.80%	4.30%	9.10%	-4.80%	7.60%	5.40%	13.20%
	8.70%	-3.80%	-8.20%	-14.80%	-13.30%	-0.80%	-9.10%	-10.90%	-24.50%	-9.60%	-3.80%	6.10%
	3.60%	—	-1.20%	—	-1.00%	—	-1.00%	—	—	—	—	—
	110.90%	-19.20%	-4.20%	-9.80%	-9.80%	25.40%	53.30%	20.80%	—	—	—	—
	237.30%	-309.20%	13.60%	-22.90%	50.90%	90.20%	-268.70%	-316.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	394.83	345.43	340.38	257.36	217.98	212.01
	8.61	9.54	11.90	8.59	11.74	7.78
	403.44	354.98	352.28	265.95	229.72	219.79
	407.59	376.40	386.23	247.23	206.17	191.91
	178.23	169.26	178.17	173.16	146.07	132.72
	23.17	17.41	7.76	0.38	1.16	1.66
	75.76	67.28	49.66	22.78	18.00	15.37
	11.32	12.53	13.23	3.22	2.19	0.89
	34.79	34.25	35.32	9.02	5.88	6.66
	80.68	70.94	102.54	53.85	42.62	32.93
	-4.14	-21.42	-33.95	18.72	23.55	27.88
	0.00	0.00	0.00	0.00	0.00	0.00
	-4.14	-21.42	-33.95	18.72	23.55	27.88
	5.43	5.88	9.22	8.23	7.83	7.07
	-9.57	-27.31	-43.68	10.52	15.72	20.81
	-13.89	-39.62	-66.64	8.65	28.40	36.67
Key metrics
	41.97	25.36	14.60	30.96	31.62	35.43
	10.63%	7.30%	4.30%	12.00%	14.50%	16.70%
	-2.42%	-7.90%	-12.80%	4.10%	7.20%	9.80%
	—	-1.90%	-4.80%	—	—	—
	10.64%	1.50%	32.30%	18.10%	2.80%	—
	—	37.50%	-515.20%	-33.10%	-24.50%	—
	—	-1.57	-43.47	—	—	—
	—	-1.40	0.33	—	—	—
	—	0.47	0.53	—	—	—
	—	144.63	179.64	—	—	—
	—	181.1	181.9	—	—	—
Balance sheet
	—	613.30	648.53	—	—	—
	—	313.04	356.03	—	—	—
	—	1.48	0.56	—	—	—
	—	150.65	171.74	—	—	—
	—	84.72	71.95	—	—	—
	—	54.37	43.73	—	—	—
	—	201.60	198.88	—	—	—
	—	63.95	74.16	—	—	—
	—	157.39	219.30	—	—	—
	—	146.11	180.20	—	—	—
	—	24.32	104.33	—	—	—
	—	121.79	75.87	—	—	—
	—	311.58	339.00	—	—	—
Cash flow
	—	38.36	-14.39	—	—	—
	—	9.32	-137.12	—	—	—
	—	-47.05	156.09	—	—	—
	—	39.93	29.08	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	78.55	55.50	56.54	41.41	41.70	94.37	80.28	67.34	64.45	92.06	65.64	58.80
	2.95	1.05	4.44	2.28	4.21	1.62	2.26	3.79	4.60	3.90	3.24	2.40
	81.51	56.55	60.98	43.69	45.91	95.99	82.54	71.13	69.05	95.96	68.88	61.20
	74.46	51.62	59.06	40.59	42.49	82.59	78.98	62.26	61.42	79.70	64.60	54.30
	48.87	32.69	41.97	20.82	31.28	54.83	51.35	45.25	26.93	54.80	47.81	49.61
	2.54	1.04	0.69	0.31	0.00	0.00	0.00	0.49	—	0.64	0.13	—
	7.28	6.48	6.14	6.52	6.51	5.96	5.67	5.29	5.42	4.99	5.75	4.90
	0.62	0.69	0.51	0.55	0.96	1.42	1.48	1.41	0.88	1.02	1.09	0.61
	2.32	2.25	2.04	2.10	2.17	2.06	1.82	1.86	1.75	1.61	1.61	1.67
	13.03	8.77	9.67	6.30	9.54	10.32	15.12	15.52	11.68	17.23	12.01	10.56
	7.05	4.93	1.93	3.10	3.42	13.40	3.56	8.87	7.63	16.26	4.28	6.90
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	7.05	4.93	1.93	3.10	3.42	13.40	3.56	8.87	7.63	16.26	4.28	6.90
	1.63	1.27	0.55	1.18	0.69	3.40	1.10	2.37	2.14	4.08	1.33	1.83
	5.42	3.66	1.38	1.92	2.73	10.00	2.28	6.50	5.49	12.18	3.07	5.07
	7.86	5.31	2.00	2.78	3.96	14.51	3.48	8.30	7.90	20.26	5.15	8.65
Key metrics
	9.99	7.87	4.48	5.75	6.55	16.88	6.86	12.14	10.26	18.89	6.98	9.18
	12.70%	14.20%	7.90%	13.90%	15.70%	17.90%	8.50%	18.00%	15.90%	20.50%	10.60%	15.60%
	6.90%	6.60%	2.40%	4.60%	6.50%	10.60%	2.80%	9.70%	8.50%	13.20%	4.70%	8.60%
	1.80%	—	0.60%	—	1.10%	—	1.30%	—	—	—	—	—
	88.40%	-41.20%	-29.60%	-38.50%	-35.30%	2.50%	22.30%	14.50%	—	—	—	—
	98.50%	-63.40%	-39.50%	-70.50%	-50.30%	-17.90%	-25.70%	28.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	232.00	234.01	304.13	254.16	217.98	212.01
	10.72	12.55	14.56	11.96	18.84	7.78
	242.73	246.57	318.69	266.12	236.82	219.79
	225.73	224.72	282.37	235.32	204.65	191.42
	144.35	148.90	178.34	173.16	146.07	132.72
	4.58	1.00	1.13	0.41	1.16	1.66
	26.42	25.13	21.38	19.61	16.93	15.26
	2.37	3.44	4.79	3.19	2.19	0.89
	8.71	8.36	7.05	6.40	5.85	6.66
	37.77	35.84	59.54	47.73	42.20	32.55
	17.01	21.84	36.32	30.80	32.17	28.37
	0.00	0.00	0.00	—	—	—
	17.01	21.84	36.32	30.80	32.17	28.37
	4.63	5.82	9.36	8.24	7.83	7.07
	12.38	16.02	26.45	22.59	24.34	21.30
	17.95	23.24	40.36	38.81	42.40	37.11
Key metrics
	28.09	33.64	48.16	40.39	40.21	35.92
	12.11%	14.40%	15.80%	15.90%	18.40%	16.90%
	5.34%	6.80%	8.70%	8.90%	11.20%	10.00%
	—	6.00%	10.40%	—	—	—
	-18.22%	-23.10%	19.70%	16.60%	2.80%	—
	-42.45%	-39.40%	17.10%	-7.20%	14.30%	—
	—	30.05	27.37	—	—	—
	—	2.78	1.80	—	—	—
	—	0.05	0.17	—	—	—
	—	19.54	64.41	—	—	—
	—	210.0	178.6	—	—	—
Balance sheet
	—	519.94	549.19	—	—	—
	—	220.17	265.78	—	—	—
	—	0.52	0.34	—	—	—
	—	120.57	164.72	—	—	—
	—	54.33	46.85	—	—	—
	—	33.93	21.25	—	—	—
	—	49.80	45.37	—	—	—
	—	40.27	62.76	—	—	—
	—	101.87	154.63	—	—	—
	—	20.06	64.75	—	—	—
	—	6.42	62.48	—	—	—
	—	13.64	2.27	—	—	—
	—	402.34	386.82	—	—	—
Cash flow
	—	44.57	47.67	—	—	—
	—	4.14	89.70	—	—	—
	—	-48.80	69.25	—	—	—
	—	14.52	-20.30	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +2.39%
Sales CAGR 5Y: —
Profit CAGR 3Y: -13.01%
Profit CAGR 5Y: —
Sales YoY (TTM): -18.22%
Profit YoY (TTM): -42.45%

Consolidated

Sales CAGR 3Y: +16.59%
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +10.64%
Profit YoY (TTM): +64.28%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 67.22%

Quarter	September 2026	June 2026
Promoter %	67.22%	67.21%

Holder	Type	Holding	Previous	Change
DESAI SHARES AND STOCK PRIVATE LIMITED	Promoter	39.67%	39.67%	0.00%
HIMABEN BHARATBHAI DESAI	Promoter	13.97%	13.97%	0.00%
BHARATKUMAR RAMESHCHANDRA DESAI	Promoter	10.76%	10.76%	0.00%
ASOJ SOFT CAPS PVT LTD (ANCHOR)	Public	4.94%	—	—
MADHULIKA AGARWAL	Public	1.87%	1.87%	0.00%
ASHISH KACHOLIA	Public	1.87%	1.87%	0.00%
SOHINI GIRISH PATEL	Public	1.41%	1.41%	0.00%
MANOHAR DEVABHAKTUNI	Public	1.37%	1.37%	0.00%
BHAHIM BHARATKUMAR DESAI	Promoter	1.30%	1.29%	+0.01%
NIKITA BHAHIM DESAI	Promoter	1.22%	1.22%	0.00%
VARENYAM HEALTHCARE PRIVATE LIMITED	Promoter	0.24%	0.24%	0.00%
SHAILESH GOVINDLAL DESAI	Promoter	0.04%	0.04%	0.00%
POOJA P SHAH	Promoter	0.01%	0.01%	0.00%
LATABEN SHAILESHKUMAR PARIKH	Promoter	0.01%	0.01%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Bharat Parenterals Limited	1,241	1,801.35	-38.20	-1.90%	+10.64% TTM	+64.28% TTM	+47.36%

Filings & corporate actions

Recent announcements

Transcript of Earnings Conference Call of Q2FY27.2 Nov 2026 · Company Update / Earnings Call Transcript
Audio Recording of Q2FY27 Earnings Conference Call.30 Oct 2026 · Company Update / Analyst / Investor Meet
Please find the enclosed copies of the newspaper publication regarding unaudited standalone and Consolidate Financial result for the quarter and half-year ended on September 30, 2026.30 Oct 2026 · Company Update / Newspaper Publication
Investor Presentation for the Quarter and Half Year ended on September 30, 2026.29 Oct 2026 · Company Update / Investor Presentation
Un-Audited Standalone and Consolidated Financial Results For the Quarter and Half Year Ended On September 30, 2026.29 Oct 2026 · Result / Financial Results
Outcome of the Meeting of the Board of Director of Bharat Parenterals Limited held on October 29, 202629 Oct 2026 · Board Meeting / Outcome of Board Meeting
Please find the enclosed newspaper notice to the physical shareholders informing them about the special Window open for re-lodging the transfer deed.26 Oct 2026 · Company Update / Newspaper Publication
Approval of Preferential Issue by Shareholders of the Company through EGM Held on October 23, 2026.25 Oct 2026 · Company Update / Preferential Issue
Revised Voting Result25 Oct 2026 · AGM/EGM / EGM
Approval of Preferential Issue by shareholders of the company through EGM held on October 23, 2026.24 Oct 2026 · Company Update / Preferential Issue
Voting Results and Scrutinizer Report for the EGM held on October 23, 2026.24 Oct 2026 · AGM/EGM / EGM
Intimation of Q2FY27 Earnings Conference Call.24 Oct 2026 · Company Update / Analyst / Investor Meet
Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve Unaudited standalone and ....24 Oct 2026 · Board Meeting / Board Meeting
Proceedings of the EGM held on Friday, October 23, 2026, through Video conferencing.23 Oct 2026 · AGM/EGM / EGM
Press Release on Commencement of Commercial Supply to the U.S by Innoxel Lifesciences Private Limited, Material Subsidiary Company of Bharat Parenterals Limited.21 Oct 2026 · Company Update / Press Release / Media Release
Newspapaer Advertisement under regulation 30 of SEBI LODR (Listing Obligations and Disclosure Requirements), Regulations, 201521 Oct 2026 · Company Update / Newspaper Publication
Submission of a copy of the newspaper advertisement dated October 14, 2026, informing shareholders about the dispatch of the corrigendum to the notice of EGM to be held on October 23, 2026.14 Oct 2026 · Company Update / Newspaper Publication
We hereby submit the corrigendum to the Extra-Ordinary General Meeting to be held on October 23, 2026.13 Oct 2026 · AGM/EGM / EGM
Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 20268 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Newspaper publication for the 1st EGM of FY 2026-27.2 Oct 2026 · Company Update / Newspaper Publication
Notice of Extra -Ordinary General Meeting of the Company to be held on Friday, October 23, 2026.1 Oct 2026 · AGM/EGM / EGM
Outcome of the board meeting for the board approves the Preferential Allotment29 Sep 2026 · Board Meeting / Outcome of Board Meeting
Intimation for the closure of the trading Window in terms of the SEBI (Prohibition of Insider Trading) Regulations, 201524 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/09/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....24 Sep 2026 · Board Meeting / Board Meeting
Voting Results along with the scrutinizer report for the 33rd AGM held on Saturday, September 19, 2026.19 Sep 2026 · AGM/EGM / AGM
Intimation of Proceedings of the 33rd Annual General Meeting of the Company held on September 19, 2026.19 Sep 2026 · AGM/EGM / AGM
Public Notice for Newspaper advertisement dated September 12, 2026.14 Sep 2026 · Company Update / Newspaper Publication
Please find the enclosed newspaper publications intimating details of 33rd Annual General Meeting of the company schedule on September 19, 2026.28 Aug 2026 · Company Update / Newspaper Publication
Please find the enclosed copy of the letter dispatched by the company to the shareholders (whose email id not registered) for providing details to access the Annual Report for FY 2025-26.27 Aug 2026 · Company Update / General
Intimation of Record Date for the purpose of Payment of Dividend for the FY 2025-26.27 Aug 2026 · Corp. Action / Record Date
Annual Report for the Financial Year 2025-2627 Aug 2026 · Others / Reg. 34 (1) Annual Report
Notice of 33rd Annual General Meeting of the Company.27 Aug 2026 · AGM/EGM / AGM
Intimation for publication of Pre-Newspaper Advertisement of the 33rd Annual General Meeting of the Company.24 Aug 2026 · Company Update / Newspaper Publication
Intimation regarding permission to trade and Admission of Equity Shares to dealing on the National Stock Exchange of India Limited.20 Aug 2026 · Company Update / General
Please find the enclosed newspaper notice to the physical Shareholders informing them about the special window open for re-lodging the transfer deed.14 Aug 2026 · Company Update / Newspaper Publication
Press release on Update on Expansion and Enhancement of the facility of Varenyam Biolifesciences Pvt Ltd, a Wholly Owned Subsidiary Company of Bharat Parenterals Limited11 Aug 2026 · Company Update / Press Release / Media Release
Intimation of an analyst and investor Meet under Regulation 30 of SEBI (LODR), Regulations, 2015.10 Aug 2026 · Company Update / Analyst / Investor Meet
Copy of newspaper advertisement for the Unaudited Financial Results for the Quarter ended on June 30, 2026.7 Aug 2026 · Company Update / Newspaper Publication
Investor Presentation for the Quarter ended on June 30, 20265 Aug 2026 · Company Update / Investor Presentation
Re-appointment of Mr. Hemang Shah as Executive Director of the Company, Subject to approval of Shareholders in enuing AGM.5 Aug 2026 · Company Update / Change in Directorate

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 1.0000	11 Sep 2026	12 Sep 2026	—
Final Dividend - Rs. - 1.0000	19 Sep 2025	19 Sep 2025	—

Board meetings

29 Oct 2026 Board Meeting - Financial Results
5 Aug 2026 Board Meeting - Financial Results